-
A1417595-5mgAnticancer agent 43 (C007B-606682)
Price: $191.94List Price: $213.27Anticancer agent 43 -
Ab175465-100μgBebtelovimab (anti-Spike RBD) (C007B-542868)
Price: $179.83List Price: $199.81Bebtelovimab (anti-Spike RBD) a humanized IgG1-λ2 antibody targeting to SARS-CoV-2, especially COVID-19. Bebtelovimab (anti-Spike RBD) potently neutralizes SARS-CoV-2 variants, and inhibits COVID-19 with mild-to-moderate efficacy.Purity≥95% -
Ab175465-10mgBebtelovimab (anti-Spike RBD) (C007B-542869)
Price: $2,496.51List Price: $2,773.90Bebtelovimab (anti-Spike RBD) a humanized IgG1-λ2 antibody targeting to SARS-CoV-2, especially COVID-19. Bebtelovimab (anti-Spike RBD) potently neutralizes SARS-CoV-2 variants, and inhibits COVID-19 with mild-to-moderate efficacy.Purity≥95% -
B646611-25mgBefiradol (C007B-335726)
Price: $925.42List Price: $1,028.24Befiradol (NLX-112) is a selective 5-HT1A receptor agonist.Form:SolidIC50&: Target:5-HT 1A Receptor. -
Ab182893-100μgBepranemab (anti-Tau) (C007B-542988)
Price: $186.75List Price: $207.50Bepranemab (anti-Tau) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab (anti-Tau) can be used for Alzheimer’s disease (AD) research.Purity>:95% (SDS-PAGE&:SEC)Endotoxin -
Ab182893-10mgBepranemab (anti-Tau) (C007B-542989)
Price: $2,501.18List Price: $2,779.09Bepranemab (anti-Tau) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab (anti-Tau) can be used for Alzheimer’s disease (AD) research.Purity>:95% (SDS-PAGE&:SEC)Endotoxin -
Ab182893-1mgBepranemab (anti-Tau) (C007B-542990)
Price: $649.34List Price: $721.49Bepranemab (anti-Tau) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab (anti-Tau) can be used for Alzheimer’s disease (AD) research.Purity>:95% (SDS-PAGE&:SEC)Endotoxin -
Ab182893-5mgBepranemab (anti-Tau) (C007B-542991)
Price: $1,622.31List Price: $1,802.57Bepranemab (anti-Tau) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab (anti-Tau) can be used for Alzheimer’s disease (AD) research.Purity>:95% (SDS-PAGE&:SEC)Endotoxin -
Ab175470-100μgBermekimab (anti-IL-1a) (C007B-327811)
Price: $271.99List Price: $302.22Bermekimab (anti-IL-1a) is a human monoclonal antibody that targets interleukin-1alpa (IL-1α). Bermekimab (anti-IL-1a) prevents tumour-related inflammation. -
Ab175470-10mgBermekimab (anti-IL-1a) (C007B-327812)
Price: $6,156.86List Price: $6,840.96Bermekimab (anti-IL-1a) is a human monoclonal antibody that targets interleukin-1alpa (IL-1α). Bermekimab (anti-IL-1a) prevents tumour-related inflammation. -
Ab175470-1mgBermekimab (anti-IL-1a) (C007B-327813)
Price: $1,077.57List Price: $1,197.30Bermekimab (anti-IL-1a) is a human monoclonal antibody that targets interleukin-1alpa (IL-1α). Bermekimab (anti-IL-1a) prevents tumour-related inflammation. -
Ab175470-5mgBermekimab (anti-IL-1a) (C007B-327814)
Price: $3,847.97List Price: $4,275.52Bermekimab (anti-IL-1a) is a human monoclonal antibody that targets interleukin-1alpa (IL-1α). Bermekimab (anti-IL-1a) prevents tumour-related inflammation.
Bevacizumab
Browse our curated selection of Bevacizumab from leading global manufacturers. Find research-grade reagents, certified standards, and specialty supplies backed by Cenmed's expert sourcing and technical support.
About Bevacizumab
Cenmed Enterprises provides a comprehensive selection of Bevacizumab products sourced from leading global manufacturers. Our catalog spans research-grade reagents, certified standards, and specialty compounds used across clinical, academic, and industrial laboratories worldwide.
With decades of expertise in laboratory supply distribution, we offer competitive pricing, reliable stock availability, and dedicated technical support. Whether you need small quantities for research or bulk orders for manufacturing, our team is ready to assist with sourcing, compliance documentation, and logistics.



